Abstract BRAF (V600E) mutation is the most frequent genetic alteration in papillary thyroid
carcinomas (PTCs) that are 80–90% of all thyroid cancers. We evaluated the relationship …

Background Lymph node metastasis (LNM) is associated with increased risk of recurrence
and poor prognosis in papillary thyroid cancer (PTC). Novel non-invasive biomarkers for the …

Purpose This study investigated the utility of BRAF mutation testing of thyroid fine-needle
aspiration biopsy (FNAB) specimens for preoperative risk stratification in papillary thyroid …

Background The objective of this study is to perform a meta-analysis to evaluate the
associations between the BRAF V600E mutation status and aggressive clinicopathological …

Papillary thyroid carcinomas (PTC) are the most common thyroid tumors that usually have a
good prognosis. Recurrence, metastases, and cancer death may occur in a few patients and …

Background This study analyzed the utility of BRAF mutation screening of ultrasonography-
guided fine-needle aspiration biopsy (FNAB) specimens for predicting aggressive …

The prognostic value of the BRAFV600E mutation, resulting in poor clinical outcomes of
papillary thyroid carcinoma, has been generally confirmed. However, the association of …

In the recent years, a large number of molecular alterations in thyroid cancer has been
discovered and characterized. Some of these markers may have significant diagnostic utility …

Context: Evaluation of the degree of neoplastic infiltration beyond the thyroid capsule
remains a unique parameter that can be evaluated by histopathological examination to label …

Background Papillary thyroid carcinoma (PTC) is the most common thyroid cancer. While
many patients survive, a portion of PTC cases display high aggressiveness and even …